Home | | Microbiology and Immunology | Treatment, Prevention and Control - Candida albicans Infections

Chapter: Microbiology and Immunology: Mycology, Fungi: Opportunistic Fungal Infections

Treatment, Prevention and Control - Candida albicans Infections

Antifungal therapy forms the mainstay of treatment of the infections caused by Candida.

Treatment

Antifungal therapy forms the mainstay of treatment of the infections caused by Candida. These agents include azoles (fluconazole, triazole, ketoconazole), nystatin, and amphoteri-cin B. C. glabrata is becoming increasingly important worldwide and is intrinsically less susceptible to amphotericin B and other azoles (ketoconazole, fluconazole, etc). Candida krusei is increasingly recognized because of its resistance to many anti-fungal agents. It is intrinsically resistant to ketoconazole and fluconazole. It is also less susceptible to all other antifungal agents including itraconazole and amphotericin B. C. lusitaniae is also of clinical significance because it is resistant to ampho-tericin B, but it is susceptible to azoles and echinocandins.

Prevention and Control

Antifungal prophylaxis is indicated for patients with invasive candidiasis who are at high risk of developing invasive candi-diasis. There is no vaccine available against candidiasis.


Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Microbiology and Immunology: Mycology, Fungi: Opportunistic Fungal Infections : Treatment, Prevention and Control - Candida albicans Infections |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.